These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10386656)

  • 21. T1-T2 carcinoma of the glottis: relative hypofractionation.
    Randall ME; Springer DJ; Raben M
    Radiology; 1991 May; 179(2):569-71. PubMed ID: 2014313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can I treat this small larynx lesion with radiation alone? Update on the radiation management of early (T1 and T2) glottic cancer.
    Kadish SP
    Otolaryngol Clin North Am; 2005 Feb; 38(1):1-9, vii. PubMed ID: 15649494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simulation study of high-dose-rate brachytherapy for early glottic cancer.
    Hoffman MR; McCulloch TM; Mohindra P; Das R; Geurts M; Harari PM
    Brachytherapy; 2016; 15(1):94-101. PubMed ID: 26614234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conventional fractionation should not be the standard of care for T2 glottic cancer.
    Dixon LM; Douglas CM; Shaukat SI; Garcez K; Lee LW; Sykes AJ; Thomson D; Slevin NJ
    Radiat Oncol; 2017 Nov; 12(1):178. PubMed ID: 29137654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced regeneration response of laryngeal and hypopharyngeal mucosa with accelerated hyperfractionated radiation therapy for glottic cancers.
    Mariya Y; Matsutani H; Abe Y; Nakaji S
    Radiat Med; 1998; 16(6):469-72. PubMed ID: 9929148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.
    Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
    Strahlenther Onkol; 1992 Oct; 168(10):579-83. PubMed ID: 1440229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fractionation and glottic carcinoma.
    Fowler JF
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):1-2. PubMed ID: 9300733
    [No Abstract]   [Full Text] [Related]  

  • 30. Patterns of fractionation for patients with T2N0M0 glottic larynx cancer undergoing definitive radiotherapy in the United States.
    Stokes WA; Stumpf PK; Jones BL; Blatchford PJ; Karam SD; Lanning RM; Raben D
    Oral Oncol; 2017 Sep; 72():110-116. PubMed ID: 28797446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unexpected radiation laryngeal necrosis after carbon ion therapy using conventional dose fractionation for laryngeal cancer.
    Demizu Y; Fujii O; Nagano F; Terashima K; Jin D; Mima M; Oda N; Takeuchi K; Takeda M; Ito K; Fuwa N; Okimoto T
    Jpn J Clin Oncol; 2015 Nov; 45(11):1076-81. PubMed ID: 26355161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microlaryngoscopic surgery for T1 glottic lesions: a cost-effective option.
    Perry A
    Ann Otol Rhinol Laryngol; 1995 Jan; 104(1):85. PubMed ID: 7832547
    [No Abstract]   [Full Text] [Related]  

  • 34. Voice outcomes following radiation versus laser microsurgery for T1 glottic carcinoma: systematic review and meta-analysis.
    Greulich MT; Parker NP; Lee P; Merati AL; Misono S
    Otolaryngol Head Neck Surg; 2015 May; 152(5):811-9. PubMed ID: 25837666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of conventional or hypofractionated radiotherapy on voice quality and oncological outcome in patients with early glottic cancer.
    Di Nicola L; Gravina GL; Marampon F; Bonfili P; Buonopane S; Di Staso M; Festuccia C; Franzese P; Tombolini M; Tombolini V
    Oncol Rep; 2010 Nov; 24(5):1383-8. PubMed ID: 20878134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early-stage glottic cancer: importance of dose fractionation in radiation therapy.
    Kim RY; Marks ME; Salter MM
    Radiology; 1992 Jan; 182(1):273-5. PubMed ID: 1727295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electron beam treatment of early glottic lesions.
    Soni SC; Khan FR; Ovadia J; Nickson JJ
    J Radiol Electrol Med Nucl; 1974; 55(6-7):481-3. PubMed ID: 4214457
    [No Abstract]   [Full Text] [Related]  

  • 38. Radiotherapy in early glottic carcinoma.
    Kanonier G; Fritsch E; Rainer T; Thumfart WF
    Ann Otol Rhinol Laryngol; 1996 Oct; 105(10):759-63. PubMed ID: 8865769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of endolaryngeal surgery (with or without laser) versus radiotherapy in the management of early (T1) glottic cancer: a systematic review.
    Yoo J; Lacchetti C; Hammond JA; Gilbert RW;
    Head Neck; 2014 Dec; 36(12):1807-19. PubMed ID: 24115131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions.
    Ermiş E; Teo M; Dyker KE; Fosker C; Sen M; Prestwich RJ
    Radiat Oncol; 2015 Sep; 10():203. PubMed ID: 26395876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.